Southport Capital Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,563
Closed -$252K 264
2021
Q4
$252K Buy
4,563
+332
+8% +$18.3K 0.04% 283
2021
Q3
$202K Sell
4,231
-3,808
-47% -$182K 0.08% 221
2021
Q2
$400K Sell
8,039
-953
-11% -$47.4K 0.1% 200
2021
Q1
$401K Buy
8,992
+1,469
+20% +$65.5K 0.11% 199
2020
Q4
$346K Sell
7,523
-619
-8% -$28.5K 0.12% 158
2020
Q3
$383K Sell
8,142
-196
-2% -$9.22K 0.15% 150
2020
Q2
$425K Sell
8,338
-296
-3% -$15.1K 0.18% 130
2020
Q1
$409K Sell
8,634
-22,958
-73% -$1.09M 0.22% 115
2019
Q4
$1.86M Sell
31,592
-1,756
-5% -$103K 0.72% 36
2019
Q3
$1.78M Buy
33,348
+37
+0.1% +$1.97K 0.8% 34
2019
Q2
$1.67M Sell
33,311
-4,871
-13% -$244K 0.76% 40
2019
Q1
$2M Sell
38,182
-4,336
-10% -$227K 0.89% 30
2018
Q4
$2.03M Sell
42,518
-1,605
-4% -$76.7K 1.02% 22
2018
Q3
$2.22M Sell
44,123
-1,559
-3% -$78.3K 0.94% 26
2018
Q2
$2.3M Sell
45,682
-3,944
-8% -$199K 1.04% 25
2018
Q1
$2.42M Buy
49,626
+5,567
+13% +$272K 1.08% 27
2017
Q4
$1.95M Buy
44,059
+1,717
+4% +$76.1K 0.74% 44
2017
Q3
$2.15M Buy
42,342
+3,182
+8% +$161K 0.91% 35
2017
Q2
$2.11M Buy
39,160
+5,435
+16% +$293K 0.93% 32
2017
Q1
$1.78M Buy
33,725
+10,787
+47% +$568K 1% 31
2016
Q4
$1.1M Buy
22,938
+1,179
+5% +$56.7K 0.67% 49
2016
Q3
$1.17M Buy
21,759
+656
+3% +$35.4K 0.82% 39
2016
Q2
$1.14M Sell
21,103
-430
-2% -$23.3K 0.64% 46
2016
Q1
$1.09M Sell
21,533
-386
-2% -$19.6K 0.7% 50
2015
Q4
$1.11M Sell
21,919
-2,387
-10% -$120K 0.71% 48
2015
Q3
$1.17M Buy
24,306
+56
+0.2% +$2.69K 0.79% 44
2015
Q2
$1.26M Sell
24,250
-1,748
-7% -$91K 0.76% 45
2015
Q1
$1.5M Buy
25,998
+113
+0.4% +$6.52K 0.89% 38
2014
Q4
$1.38M Buy
25,885
+3,673
+17% +$196K 0.83% 39
2014
Q3
$1.28M Buy
22,212
+15,118
+213% +$868K 0.84% 41
2014
Q2
$474K Sell
7,094
-240
-3% -$16K 0.32% 81
2014
Q1
$490K Sell
7,334
-1,748
-19% -$117K 0.34% 81
2013
Q4
$606K Buy
9,082
+762
+9% +$50.8K 0.43% 74
2013
Q3
$522K Buy
+8,320
New +$522K 0.41% 76